Total Funding
1
10
Total FundingVenture - Series Unknown raised
Growth Score
-5 pts
Heat Score
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
932162
Perseus Holdings is an immuno-oncology company that is focused on the development and commercialization of immune-mediated technologies.
- Buddy Long: CEO
About the Company
Perseus Holdings is an immuno-oncology company that is focused on the development and commercialization of immune-mediated technologies for the treatment of cancer. The company holds executive licenses for the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine, and the tumor lysate, particle only (TLPO) vaccine – both personalized
therapeutic cancer vaccines designed to attack cancer cells by igniting innate and adaptive immune responses which increase a patient's own production of T cells to fight their specific cancer.
Perseus Holdings was founded in 2014 and is based in Austin, Texas.
